IHH Healthcare Bhd.

In the news

Malaysia shortlists nine hospitals to boost medical tourism Sep 24, 2019
Asian equities advance ahead of Federal Reserve rate decision Sep 18, 2019
IHH buys luxury Kuala Lumpur hospital for $244m Sep 18, 2019
Hospital giant IHH seeks healthy returns on India and China bets Sep 6, 2019
Malaysia sovereign wealth fund marks $1.5bn loss over impairments Mar 6, 2019

See more articles on IHH Healthcare Bhd.

Company Background

IHH Healthcare runs 37 private hospitals in 10 countries, including China and India. Its facilities have a total of more than 6,000 beds.

Headquartered in Malaysia, the company also sees Singapore and Turkey as its home markets. Its hospitals in these three countries attract affluent patients from across Southeast Asia and the Middle East. The group's Mount Elizabeth and Gleneagles hospitals in Singapore are considered particularly prestigious, thanks to their state-of-the-art medical equipment.

IHH is 44% owned by Khazanah Nasional, an investment arm of the Malaysian government. Khazanah in 2010 defeated a rival bid from India's Fortis Healthcare to take control of Parkway Holdings, a then-listed Singaporean company, which owned hospitals in Malaysia and Singapore. Today, Parkway is a wholly owned IHH subsidiary.

IHH is listed in both Malaysia and Singapore. The group is led by CEO Tan See Leng, who is also a doctor. Tan joined Parkway in 2004 and held various high-ranking positions before the company slid under IHH's umbrella.

Globally, IHH is the second-largest health care operator by market capitalization. Japanese trading house Mitsui & Co. is a major shareholder.

Business Summary

IHH Healthcare Bhd. is an investment holding company, which engages in the provision of healthcare services. It operates through the following segments: Parkway Pantai, PPL Others, CEEMENA, and Others. The Parkway Pantai segment comprises the Parkway Pantai and PLife REIT. The PPL Others segment includes Pantai's hospital in Brunei, and corporate office as well as other investment holding entities within Parkway Pantai. The CEEMENA segment refers to Central and Eastern Europe, Middle East, and North Africa. The company was founded on May 21, 2010 and is headquartered in Kuala Lumpur, Malaysia.

Financial Highlights

Dec 2018	MYR	USD
Revenue	11,520.93M	2,854.98M
Gross Profit	2,902.27M	719.20M
Operating income	1,240.72M	307.46M
Income before tax	739.05M	183.14M
Net income	541.84M	134.27M
EBITDA	2,162.14M	535.79M
Diluted EPS	0.06	0.01
Dividends Per Share	0.03	0.00
Total Assets	45,114.51M	10,917.00M
Total liabilities	18,765.36M	4,540.92M
Total equity	21,994.00M	5,322.20M
Operating cash flow	1,562.71M	387.25M
	Currency in MYR	Currency in USD

Historical Data

MYR | USD

	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018
Revenue	7,344.01M	8,455.46M	10,021.88M	11,142.63M	11,520.93M
Gross Profit	2,020.36M	2,327.18M	2,657.91M	2,620.19M	2,902.27M
Operating income	1,074.16M	1,210.55M	1,227.74M	1,068.88M	1,240.72M
Income before tax	1,211.32M	1,203.25M	860.94M	1,162.33M	739.05M
Net income	754.29M	933.90M	612.35M	931.31M	541.84M
EBITDA	1,682.34M	1,900.05M	2,026.87M	2,046.96M	2,162.14M
Diluted EPS	0.09	0.11	0.07	0.11	0.06
Dividends Per Share	0.03	0.03	0.03	0.03	0.03
Total Assets	28,680.13M	35,517.48M	37,200.39M	38,925.48M	45,114.51M
Total liabilities	7,366.73M	11,280.78M	13,307.23M	15,183.41M	18,765.36M
Total equity	19,451.74M	22,155.73M	21,985.74M	21,890.16M	21,994.00M
Operating cash flow	1,557.92M	1,863.97M	1,730.45M	2,006.03M	1,562.71M

	Dec 2014	Dec 2015	Dec 2016	Dec 2017	Dec 2018
Revenue	2,244.48M	2,162.70M	2,419.15M	2,591.60M	2,854.98M
Gross Profit	617.46M	595.23M	641.58M	609.41M	719.20M
Operating income	328.28M	309.63M	296.36M	248.60M	307.46M
Income before tax	370.20M	307.76M	207.82M	270.34M	183.14M
Net income	230.52M	238.86M	147.81M	216.60M	134.27M
EBITDA	514.16M	485.98M	489.26M	476.09M	535.79M
Diluted EPS	0.02	0.02	0.01	0.02	0.01
Dividends Per Share	0.00	0.00	0.00	0.00	0.00
Total Assets	8,202.52M	8,272.38M	8,292.55M	9,618.35M	10,917.00M
Total liabilities	2,106.88M	2,627.40M	2,966.39M	3,751.77M	4,540.92M
Total equity	5,563.20M	5,160.29M	4,900.96M	5,408.98M	5,322.20M
Operating cash flow	476.13M	476.75M	417.70M	466.57M	387.25M

Valuation Measures

Dec 2018
PER	82.41
ROA	1.28%
ROE	2.46%
Operating margin	10.76%
Profit margin	4.70%

Key executives

CEO-Designate & Executive Director: Chi-Keon Loh
CEO, MD & Non-Independent Executive Director: See Leng Tan
Group Chief Operating Officer: Suet Wun Lim
Group Chief Financial Officer: Soon Teck Low
Group Head-Internal Audit: Audrey Huang

Shareholders

Mitsui & Co., Ltd. (32.9%)
Khazanah Nasional Bhd. (Investment Company) (26.0%)
Employees Provident Fund (6.8%)
Permodalan Nasional Bhd. (4.8%)
AYDINLAR MEHMET ALI (4.7%)
Public Mutual Bhd. (2.1%)
Kuwait Investment Authority (Investment Management) (1.6%)
Kumpulan Wang Persaraan (1.5%)
The Vanguard Group, Inc. (1.1%)
GIC Pte Ltd. (Investment Management) (1.0%)

Contact Details

Website:http://www.ihhhealthcare.com
Address: Level 11 Block A, Pantai Hospital, Kuala Lumpur, 8 Jalan Bukit Pantai, Kuala Lumpur, 59100, Malaysia
Phone: +60.3.2298.9898

Related Companies

Northern TK Venture Pte Ltd.
IHH Healthcare Bhd. (Singapore)
Centre For Digestive & Kidney Diseases India Pvt Ltd.
Acibadem Saglik Yatirimlari Holding AS
Indah Capital Ltd.
Shanghai Mai Kang Hospital Investment Management Co. Ltd.
Bodrum Tedavi Hizmetleri A.S
Integrated Healthcare Turkey Yatirimlari Ltd.
Gleneagles Development Pte Ltd.
Integrated Healthcare Holdings Ltd.
Acibadem Saglik Hizmetleri ve Ticaret AS
Pantai Holdings Sdn. Bhd.
Parkway Holdings Ltd.

Competitors

Last Updated on 23 Oct, 2019